Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for levodopa-induced dyskinesia in Parkinson's disease
IRCT20190427043389N5Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron in Parkinson's disease (PD) and levodopa-induced dyskinesia (LID), sponsored by Zanjan University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
ondansetron
03
Conditions
Parkinson's disease (PD)levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on IRCT20190427043389N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190427043389N5.